alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
CERTIFICATIONS
PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002


(18
U.S.C. SECTION 1350)





In
connection with the Annual Report of Javo Beverage Company, Inc., a Delaware
corporation (the “Company”), on Form 10-K for the year ended December 31, 2009,
as filed with the Securities and Exchange Commission (the “Report”), Cody C.
Ashwell, Chief Financial Officer of the Company, does hereby certify, pursuant
to § 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. § 1350), that to his
knowledge:





(1) The
Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and





(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and result of operations of the Company.











/s/
Richard A. Gartrell
 Richard
A. Gartrell
 Chief
Financial Officer
 March 16,
2010
  [A signed
original of this written statement required by Section 906 has been provided to
Javo Beverage Company, Inc. and will be retained by Javo Beverage Company, Inc.
and furnished to the Securities and Exchange Commission or its staff upon
request.]
AO 247 (Rev. 11/11) Order Regarding Motion for Sentence Reduction Pursuant to 18 U.S.C. § 3582(c)(2) Page 1 of 2 (Page 2 Not for Public Disclosure)

UNITED STATES DISTRICT COURT

for the

__________ District of __________

United States of America

)

)

)

)

)

)

v.

Case No:

USM No:

Date of Original Judgment:

Date of Previous Amended Judgment:

(Use Date of Last Amended Judgment if Any) Defendant’s Attorney

	
	


	




Upon motion of the defendant the Director of the Bureau of Prisons the court under 18 U.S.C.

§ 3582(c)(2) for a reduction in the term of imprisonment imposed based on a guideline sentencing range that has

subsequently been lowered and made retroactive by the United States Sentencing Commission pursuant to 28 U.S.C.

§ 994(u), and having considered such motion, and taking into account the policy statement set forth at USSG §1B1.10

and the sentencing factors set forth in 18 U.S.C. § 3553(a), to the extent that they are applicable,

		 that the motion is:

DENIED. GRANTED and the defendant’s previously imposed sentence of imprisonment (as reflected in 

the last judgment issued) of months  ! "# .

(Complete Parts I and II of Page 2 when motion is granted)

Except as otherwise provided, all provisions of the judgment dated shall remain in effect.

		.

Order Date:

Judge’s signature

Effective Date:

(if different from order date) Printed name and title

 Southern District of Alabama

DARREL ONEAL THOMPSON 06-00176-001

09560-003

08/06/2007

03/10/2009 Pro Se

✔

✔

262 210 months

08/06/2007

03/22/2012 /s/ Callie V. S. Granade

United States District Judge

Case 2:06-cr-00176-CG-N Document 815 Filed 03/22/12 Page 1 of 1
11527.

#### Grove Realty Co. *v.*Forrest & George Adair.

Decided January 27, 1921.

Complaint; from Fulton superior court- — -Judge Ellis. March 19, 1920.

Application for certiorari was denied by the Supreme Court.

*Anderson, Rountree & Crenshaw,*for plaintiff in error.

*Rosser, Slaton, Phillips & Hoplcins,*contra.

Per Curiam.

1. Where an owner of realty lists it for sale with two or more brokers, and 'A, one of the brokers, finds a customer, shows him the property, and interests him so therein that he (the customer) finally buys it, A is the real procuring cause of the sale, and is entitled to his commissions from the owner, although the deal is actually closed by B, another broker with whom the property is listed, where the only cause inducing the purchaser to close the deal with B, instead of with A, is a reduction of the price by the owner through B, which reduced price A has not been authorized by the owner to offer, and where the owner, before paying a commission to any one, is notified of A’s claim to the commissions as being the procuring cause of the sale. See, in this connection, *Graves*v. *Hunnicutt,*8 *Ga. App.*99 (68 S. E. 558), and citations.

2. None of the excerpts from the charge of the court, complained of, when considered in the light of the'entire charge and of the facts of the-case, requires a reversal of the judgment below.

3. The verdict was authorized by the evidence, and the court did not err in overruling the motion for a new trial.

*Judgment affirmed.*

*Broyles, O. J., and Bloockvorth, J., concur. Lulce, J., dissents.*

Luke, J.,

dissenting. I do not agree to the judgment in this case, because, where a principal lists property for sale with several brokers (and with no one of them exclusively), and a sale to the alleged customer of one of them is actually closed by another, the broker -claiming to have effected the sale, in order to recover his commissions for so doing, must show not only that during his agency he was the procuring cause of the sale, but also that the principal in some way showed bad faith towards him in the transaction. *221*Doonan*v. *Ives,*73 *Ga. 295; Gresham*v. *Connolly,*114 *Ga.*906; (41 S. E. 42); *Floyd*v. *Boyd,*16 *Ga. App.*43, 48 (84 S. E. 494). In this case it appears that the principal had no knowledge whatever of the agent’s negotiations with his prospective customer until after it had entered into a building contract through another agent to sell the place to that customer. No bad faith is shown on the part of the principal; and it follows, in my opinion, that the verdict in favor of the plaintiff was without evidence to sustain it, and that the judge erred in overruling the general grounds of the motion for a new trial.
**EXHIBIT 11**

 

**TELLABS, INC.**

**COMPUTATION OF PER SHARE EARNINGS**

(In millions, except per share amounts)

 
| ** **                                                            | ** ** | **Three Months Ended** | ** ** | **Nine Months Ended** | ** ** |
|-----------------------------------------------------------------------|------------|------------------------|------------|-----------------------|------------|
| ** **                                                            | ** ** | **9/30/05**            | ** ** | **10/1/04**           | ** ** | **9/30/05** | ** ** | **10/1/04** | ** ** |
| Numerator:                                                            |       |                   |       |                  |       |   |   |   |   |
| Net earnings                                                          |       | $                      | 41.9       |                  | $          | 45.9 |   | $ | 83.7 |   | $ | 108.9 |   |
|                                                                  |       |                   |       |                  |       |   |   |   |   |
| Denominator:                                                          |       |                   |       |                  |       |   |   |   |   |
| Denominator for basic earnings per share-                             |       |                   |       |                  |       |   |   |   |   |
| Weighted-average shares outstanding                                   |       | 447.8                  |       | 416.7                 |       | 450.4 |   | 416.0 |   |
| Effect of dilutive securities:                                        |       |                   |       |                  |       |   |   |   |   |
| Employee stock options and awards                                     |       | 5.4                    |       | 4.0                   |       | 4.0 |   | 4.0 |   |
| Denominator for diluted earnings per share-                           |       |                   |       |                  |       |   |   |   |   |
| Adjusted weighted-average shares outstanding  and assumed conversions |       | 453.2                  |       | 420.7                 |       | 454.5 |   | 420.0 |   |
|                                                                  |       |                   |       |                  |       |   |   |   |   |
| Net earnings per share – basic                                   |       | $                      | 0.09       |                  | $          | 0.11 |   | $ | 0.19 |   | $ | 0.26 |   |
| Net earnings per share – diluted                                 |       | $                      | 0.09       |                  | $          | 0.11 |   | $ | 0.18 |   | $ | 0.26 |   |

 

19

----
#### Elba Negron, Respondent, v St. Barnabas Nursing Home et al., Appellants.

[963 NYS2d 101]

Order, Supreme Court, Bronx County (Howard H. Sherman, J.), entered March 9, 2012, which, to the extent appealed from as limited by the briefs, upon reargument, denied defendant nursing home’s motion for summary judgment, unanimously reversed, on the law, without costs, and the motion granted. The Clerk is directed to enter judgment dismissing the complaint as against the nursing home.

In this medical malpractice and negligence action, defendants made a prima facie showing of their entitlement to judgment as a matter of law by submitting, among other things, their expert affirmation and medical records *(see Alvarez v Prospect Hosp.,*68 NY2d 320, 325 [1986]). The medical records support defendants’ expert’s opinion that decedent’s chronic skin ulcers, gangrene and above-the-knee amputations, were the unavoidable result of his preexisting, chronic conditions, as well as other risk factors.

In opposition, plaintiff failed to raise a triable issue of fact. Plaintiff submitted the conclusory and speculative affirmation of an unnamed expert who failed to identify specific departures made by the nursing home, when other actions should have been taken by the nursing home and by whom, and how the results would have been different had those actions been taken *(see Alvarez,*68 NY2d at 327; *Abalola v Flower Hosp.,*44 AD3d 522 [1st Dept 2007]). These failures are especially troublesome, given plaintiffs expert’s concession that decedent’s preexisting conditions placed him at an increased risk for the conditions at issue. Moreover, the expert failed to address the evidence supporting vascular involvement and failed to establish that the nursing home’s negligence, and not the natural progress of *502decedent’s diseases and conditions, was a substantial factor in producing the injury *(see Aparicio v Goldberg,*94 AD3d 502, 503 [1st Dept 2012]; *Mortensen v Memorial Hosp.,*105 AD2d 151, 158 [1st Dept 1984]).

Concur—Gonzalez, EJ., Friedman, AbdusSalaam, Román and Clark, JJ.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

                    The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and                           ( print page 42)                        the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.                

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel Member Conflict: AIDS and AIDS Related Research.                    

*Date:*                         January 9-10, 2015.                    

*Time:*                         9:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Mary Clare Walker, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5208, MSC 7852, Bethesda, MD 20892, (301) 435-1165,                         *walkermc@csr.nih.gov.*

This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)

Dated: December 29, 2014.

Anna Snouffer,

Deputy Director, Office of Federal Advisory Committee Policy.

[FR Doc. 2014-30762 Filed 12-31-14; 8:45 am]

BILLING CODE 4140-01-P
#### The Barracouta. Cumming *et al. v.*The Barracouta.

*(District Court, S. D. New York.*

July 3, 1889.)

Shipping—Bill of Lading—Negligence.

Chlorides having been shipped in barrels, instead of the usual carboys, on their arrival a part was found lost by leakage. The bill of lading excepted liability for leakage. *Held,*that negligence in the ship must be shown to render the vessel liable for the loss, and, the cargo appearing to be well stowed, and no actual negligence proved, the libel was dismissed.

In Admiralty. Libel for loss of portion of cargo.

*Arnold & Greene,*for libelants.

*Wing, Shoudy & Putnam*and *G. G. Burrlingham,*for claimants.

Brown, J.

The above libel is filed for the loss of a portion of the contents of barrels of chloride, and 20 kegs of salt on a voyage from New York to Trinidad, in December, 1887. The bill of lading excepted liability for loss from “leakage, ” “effect of climate,” and “heat of holds,” and forbade “liquids or goods capable of doing damage being shipped, without the nature of their contents being conspicuously marked on the outside of each package.” It is evident from the testimony that the loss arose from leakage, and it is incumbent upon the libelant, therefore, to prove negligence on the part of the ship. The weight of evidence shows that such chlorides have heretofore been mostly shipped in carboys. In this case castor-oil barrels were used, and between 600 and 700 pounds were put in each barrel. The use of barrels, if safe, is doubtless much more economical and less subject to breakage. The evidence shows that barrels have been employed to some extent, while some large dealers are wholly ignorant of such use, and testified that barrels were improper and unsafe packages. The correspondence between the parties seems to indicate that the barrels in this case were tried to some extent as an experiment. Without regard to these circumstances, however, I think the libelants fail to establish any such negligence on the part of the ship, as is necessary to a recovery. *The Invincible, 1*Low, 225. The goods were well stowed in the hold, being undisturbed by a hurricane of great violence. Four barrels were found empty, or nearly so, when discharged, having the heads bulged outwards. The evidence also shows that the rest of these packages leaked, while the rest of the cargo in the hold was in perfect condition. There is no proof of improper stowage, and the only reasonable inference that can be drawn is that the barrels were insufficient for the weight put into them, and for chemicals of such a quality as they contained. No negligence being established, the libel must be dismissed, with costs.
EXHIBIT 31.2

                             Edgar Filing.Net, Inc.

                     CERTIFICATIONS PURSUANT TO SECTION 302
                       OF THE SARBANES-OXLEY ACT OF 2002


I, Danny L. Pixler, the Registrant's Chief Financial Officer, certify that:

1.   I have reviewed this annual report on Form 10-KSB of Edgar Filing.Net,  Inc
     for the fiscal year ended December 31, 2003;

2.   Based on my  knowledge,  this  annual  report  does not  contain any untrue
     statement of a material fact or omit to state a material fact  necessary to
     make the statements  made, in light of the  circumstances  under which such
     statements  were made, not misleading with respect to the period covered by
     this annual report;

3.   Based on my  knowledge,  the  financial  statements,  and  other  financial
     information included in this annual report,  fairly present in all material
     respects the financial  condition,  results of operations and cash flows of
     the registrant as of, and for, the periods presented in this annual report;

4.   I am responsible for establishing and maintaining  disclosure  controls and
     procedures  (as  defined in Exchange  Act Rules  13a-14 and 15d-14) for the
     Registrant and I have:

     a)   Designed  such  disclosure  controls  and  procedures  to ensure  that
          material  information  relating  to  the  registrant,   including  its
          consolidated subsidiaries,  is made known to me by others within those
          entities,  particularly  during the period in which this annual report
          is being prepared; and

     b)   Evaluated the  effectiveness of the Registrant's  disclosure  controls
          and procedures as of a date within 90 days prior to the filing date of
          this annual report (the "Evaluation  Date");  and

     c)   presented in this annual report my conclusions about the effectiveness
          of the disclosure controls and procedures based on my evaluation as of
          the Evaluation Date;

5. I have disclosed,  based on my most recent  evaluation,  to the  Registrant's
auditors and the audit committee of Registrant's  board of directors (or persons
performing the equivalent  function):

a)   all  significant  deficiencies  in the  design  or  operation  of  internal
     controls which could adversely affect the  Registrant's  ability to record,
     process,  summarize and report  financial data and have  identified for the
     Registrant's auditors any material weaknesses in internal controls; and

b)   any fraud,  whether or not  material,  that  involves  management  or other
     employees  who  have  a  significant  role  in  the  Registrant's  internal
     controls; and

6. I have indicated in this annual report whether or not there were  significant
changes in internal controls or in other factors that could significantly affect
internal controls subsequent to the date of my most recent evaluation, including
any  corrective  actions with regard to  significant  deficiencies  and material
weaknesses.

Date: March 29, 2004

/s/  Danny L. Pixler
----------------------
Chief Financial Officer
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2390 Introduced in House (IH)]

<DOC>

118th CONGRESS
  1st Session
                                H. R. 2390

  To authorize the appropriation of funds to the Centers for Disease 
    Control and Prevention for conducting or supporting research on 
              firearms safety or gun violence prevention.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             March 29, 2023

  Ms. Slotkin (for herself, Mr. Vargas, Ms. Dean of Pennsylvania, Ms. 
Norton, Ms. Brown, Mr. Beyer, Mr. Johnson of Georgia, Mr. Auchincloss, 
 Ms. Sewell, Mr. Sarbanes, Ms. Strickland, Ms. Kuster, Mr. Trone, Mr. 
 Torres of New York, Mr. Costa, Ms. Williams of Georgia, Ms. Bush, Ms. 
 Ross, Ms. Kelly of Illinois, and Mr. Takano) introduced the following 
    bill; which was referred to the Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL

 
  To authorize the appropriation of funds to the Centers for Disease 
    Control and Prevention for conducting or supporting research on 
              firearms safety or gun violence prevention.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Gun Violence Prevention Research Act 
of 2023''.

SEC. 2. FUNDING FOR RESEARCH BY CDC ON FIREARMS SAFETY OR GUN VIOLENCE 
              PREVENTION.

    There is authorized to be appropriated to the Centers for Disease 
Control and Prevention $50,000,000 for each of fiscal years 2024 
through 2029 for the purpose of conducting or supporting research on 
firearms safety or gun violence prevention under the Public Health 
Service Act (42 U.S.C. 201 et seq.). The amount authorized to be 
appropriated by the preceding sentence is in addition to any other 
amounts authorized to be appropriated for such purpose.
                                 <all>
```
I 

118TH CONGRESS 

1ST SESSION H. R. 1894 

To provide for a limitation on availability of funds for House of 

Representatives, Other Authorized Employees for fiscal year 2024. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 29, 2023 

Mr. BIGGS (for himself, Mr. ROSENDALE, Mr. GAETZ, Mr. GOOD of Virginia, 

Mr. ROY, and Mr. CRANE) introduced the following bill; which was referred to the Committee on House Administration 

A BILL 

To provide for a limitation on availability of funds for House 

of Representatives, Other Authorized Employees for fiscal year 2024. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. LIMITATION ON AVAILABILITY OF FUNDS FOR 

4 HOUSE OF REPRESENTATIVES, OTHER AU5 THORIZED EMPLOYEES FOR FISCAL YEAR 

6 2024. 

7 Notwithstanding any other provision of the law, 

8 amounts authorized to be appropriated or otherwise availVerDate Sep 11 2014 01:47 Apr 14, 2023 Jkt 039200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H1894.IH H1894

pbinns on DSKJLVW7X2PROD with $$_JOB
2 

•HR 1894 IH

1 able for House of Representatives, Other Authorized Em2 ployees for fiscal year 2024 may not exceed $584,000. 

Æ 


pbinns on DSKJLVW7X2PROD with $$_JOB
I 

118TH CONGRESS 

1ST SESSION H. R. 2301 

To provide for a limitation on availability of funds for Department of State, 

Administration of Foreign Affairs, Educational and Cultural Exchange 

Programs for fiscal year 2024. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 29, 2023 

Mr. BIGGS (for himself, Mr. ROSENDALE, Mr. GAETZ, Mr. GOOD of Virginia, 

Mr. ROY, and Mr. CRANE) introduced the following bill; which was referred to the Committee on Foreign Affairs 

A BILL 

To provide for a limitation on availability of funds for Department of State, Administration of Foreign Affairs, 

Educational and Cultural Exchange Programs for fiscal 

year 2024. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


kjohnson on DSK79L0C42PROD with BILLS
2 

•HR 2301 IH

1 SECTION 1. LIMITATION ON AVAILABILITY OF FUNDS FOR 

2 DEPARTMENT OF STATE, ADMINISTRATION 

3 OF FOREIGN AFFAIRS, EDUCATIONAL AND 

4 CULTURAL EXCHANGE PROGRAMS FOR FIS5 CAL YEAR 2024. 

6 Notwithstanding any other provision of the law, 

7 amounts authorized to be appropriated or otherwise avail8 able for Department of State, Administration of Foreign 

9 Affairs, Educational and Cultural Exchange Programs for 

10 fiscal year 2024 may not exceed $0. 

Æ 


kjohnson on DSK79L0C42PROD with BILLS